Treatment of Pneumonia Antibiotic Therapy in Resistant Pneumonia

TreatmentCestodes Tape Worms Taenia Saginata & Solium cysticercii neurocysticercosis Diagnosis Treatment. Read more ... » of Pneumonia ,INDICATIONS FOR HOSPITALIZATION in Pneumonia ,Resistant Pneumonia

defined as an acuteCestodes Tape Worms Taenia Saginata & Solium cysticercii neurocysticercosis Diagnosis Treatment. Read more ... » infection of the pulmonary parenchyma in a patient who has acquired the infection in the community, as distinguished from hospital-acquired (nosocomial) pneumonia,

No comorbidities or recent antibiotic use and Comorbidities or recent antibiotic use Treatment according the condition.

causes of Pneumonia

Treatment of Pneumonia ,INDICATIONS FOR HOSPITALIZATION in Pneumonia ,Resistant Pneumonia

Risk factors for drug Resistant Pneumonia —

INDICATIONS FOR HOSPITALIZATION in Pneumonia —

  • CURB-65 uses five prognostic variables  :
    1. Confusion (based upon a specific mental test or disorientation to person, place, or time)
    2. Urea (blood urea nitrogen in the United States) >7 mmol/L (20 mg/dL)
    3. Respiratory rate >30 breaths/minute
    4. Blood pressureChronic Long-term Complications Of Diabetes Mellitus. Read more ... » [BP] (systolic <90 mmHg or diastolic <60 mmHg)
    5. Age >65 years
  • The authors of the original CURB-65 report suggested that patients with a CURB-65 score of 0 to 1,
  • Those with a score of 2 should be admitted to the hospital, and those with a score of 3 or more should be assessed for ICU care, particularly if the score was 4 or 5.

No comorbidities or recent antibiotic use —

  • For uncomplicated pneumonia in patients who do not require hospitalization, have no significant comorbidities and/or use of antibiotics within the last three months,
  • Azithromycin
    • (500 mg on day one followed by four days of 250 mg a day); 500 mg a day for three days, or 2 g single dose (microsphere formulation) are acceptable alternative regimens
  • Clarithromycin
    • XL (two 500 mg tablets once daily) for five days or until afebrile for 48 to 72 hours
  • Doxycycline
    • (100 mg twice a day) for seven to 10 days

Comorbidities or recent antibiotic use —

Antibiotic Therapy  for Pneumonia

  • Macrolide plus second generation or third gen­eration cephalosporin.
  •  Clarithromycin 500 mg bd x 10 days.
  • Azithromycin 500 mg once than 250 mg od for 4 days.
  • Doxycycline 100 mg bd for 10 days.
  • Fluoroguinolone-
    • Levofloxacin500 mg od,
    • Moxifloxacin 400 mg od,
    • Gatifloxacin 400 mg od, for DRSP infection (Drug resistent Strepto pneumoniae)
  • Cefpodoxime- 200 mg bd
  • Cefuroxime axe 750 mg tid IV
  • Ceftriaxone – 1 g 12 hourly IV
  • Cefotaxime – 2 g 6 hourly IV
  • Amoxicillin + Clavulanic acid + Macrolide – 875/ 125mg tid
  • Ceftriaxone 1 g IV 12 hourly + AZithromycin 1 g IV then 500 mg after 24 hours
  • Cefotaxime + AZithromycin
  • Ampicillin + Sulbactam + Azrithromycin.

For pseudomonas infection:

  • Imipenem 500 mg 6 hourly IV I Meropenem
  • Piperacillin / Tazobactam 3.375 gm. 6 hourly IV + Ciprofloxacin 500 mg bd IV.

For aspiration pneumonia:

Duration of Antibiotic treatment:
  • Antibiotics are given for 10 – 14 days. Azithromycin is given for 5 days.

ASPIRATION PNEUMONIA

  • Aspiration pneumonia is due to foreign objects or substances entering the lower respiratory tract.
  • In the supine position the most prone areas are the posterior segments of the upper lobes and the supe­rior segments of the lower lobes.
  • Common in the elderly
  • Organisms responsible are Enterobacter, S. aureus, S. pneumonae, H influenzae.
  • In aspiration pneumonia, gastric contents or oropha­ryngeal flora are aspirated into the lungs resulting in inflammatory response and bacterial infection.
  • Aspiration is common in unconscious patients, neu­romuscular diseases.

Clinical features of Aspiration pneumonia

HOSPITAL ACQUIRED PNEUMONIA

  • HAP is defined as pneumonia occurring 48 hours af­ter hospital admission by a new pathogen.
  • It has a high morbidity and mortality.
  • It occurs in 5 – 10% of patients admitted to medical and surgical wards.
  • Incidence is highest in ICU in patients on mechanical ventilation. Patients of ventilator acquired pneumo­nia (VAP) develop the disease in 4 days of intubation.

Etiopathogenesis of Pneumonia

Clinical manifestations of nosocomial infections

Diagnosis

  • By BAL (broncho alveolar lavage), and FOB (fiberoptic bronchoscopy) .

Treatment

  • Vancomycin Linezolid.

Clinical features Pneumonia

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>